Studies have shown that shikonin may inhibit the expression of SP, NK-1R, and ICAM-1 in the skin tissue of eczema model mice, inhibit mast cell degranulation, and alleviate the symptoms of eczema inflammatory injury [19]. The gene discussed is TACR1; the disease is Eczematoid dermatitis.